Skip to main content
Log in

Non-matched images with 123I-IMP and 99mTc-bicisate single-photon emission tomography in the demonstration of focal hyperaemia during the subacute phase of an ischaemic stroke

  • Case Reports
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Focal hyperaemia is a fairly common phenomenon in the subacute phase of an ischaemic stroke. This has rarely been reported with iodine-123 iodoamphetamine (IMP) and has never been identified using technetium-99m bicisate (99mTc-ECD). In this report, we present the case of a patient suffering from a left cerebral posterior stroke. 123I-IMP single-photon emission tomography (SPET) images showed a large area of significantly increased IMP activity located in the left occipital region whereas 99mTc-bicisate SPET displayed hypoactivity in the same area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Léveillé J, Gherardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM, Van Heertum RL, Ell PJ, Buell U, De Roo MC, Morgan RA. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med 1989;30: 1018–1024

    Google Scholar 

  2. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary DH, Watson AD, Ganey MV, Morgan RA, Williams SJ. Characterization of technetium-99m-1, 1-ECD for brain perfusion imaging. Part 1. Pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med 1989;30: 1892–1901

    Google Scholar 

  3. Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC. Characterization of technetium-99m-1, 1-ECD for brain perfusion imaging. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 1989;30: 1902–1910

    Google Scholar 

  4. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1992;33: 480–484

    Google Scholar 

  5. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ. Technetium-99m-ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989;30: 599–604

    Google Scholar 

  6. Moretti JL, Askienazy S, Raynaud C, Lassen NA, Sanabria E, Desplanches C, Rapin J, Cesaro P, Marsault C, Barbizet J, Keravel Y, Fredy D. La N-isopropyl-p-iodoamphetamine I-123 en tomoscintigraphie cérébrale. Ann Radiol 1983;26: 59–67

    Google Scholar 

  7. Moretti JL, Raynaud C, Askienazy S, Sergent A, Baron JC, Samson Y, Sanabria E, Lassen N, Bourdoiseau M. Clinical applications of brain SPECT with N-isopropyl I123 p-iodoamphetamine. In: Radiopharmaceuticals and labelled compounds. IAEA 1984: 489–502

  8. Moretti JL, Cinotti L, Cesaro P, et al. Amines for brain tomoscintigraphy. Nucl Med Commun 1984;8: 581–595

    Google Scholar 

  9. Creutzig H, Schober O, Gielow P, Friedrich H, Becker H, Dietz H, Hundeshagen H. Cerebral dynamics of N-Isopropyl-(123I) p-iodoamphetamine. J Nucl Med 1986;27: 178–183

    Google Scholar 

  10. Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123, and technetium-99m HMPAO. J Nucl Med 189;30: 157–164

  11. Lassen NA, Henriksen L, Holm S, Barry DI, Paulson OB, Vorstrup S, Rapin J, Le Poncin-Lafitte M, Moretti JL, Askienazy S, Raynaud C. Cerebral blood-flow tomography: xenon-133 compared with isopropyl-amphetamine-iodine-123. J Nucl Med 1983;24: 17–24

    Google Scholar 

  12. Moretti JL, Defer G, Cinotti L, Cesaro P, Degos JD, Vigneron N, Ducassou D, Holman BL. Luxury perfusion with 99mTc HMPAO and 123I IMP SPECT imaging during the subacute phase of stroke. Eur J Nucl Med 1990;16: 17–22

    Google Scholar 

  13. Castagnoli A, Borsato N, Bruno A, et al. SPECT brain imaging in chronic stroke and dementia: a comparison of 99mTc bicisate to 99mTc HMPAO. In: Hartmann A, Hoyer S, Kuschinski W, eds. Cerebral ischemia and dementia. Stuttgart: Springer;1991: 327–333

    Google Scholar 

  14. Moretti JL, Defer G, Cinotti L, Cesaro P, Vigneron N, Pethe C. Comparative tomoscintigraphic study of strokes using ECD Tc-99m, HMPAO Tc-99m and IMP I-123. Eur J Nucl Med 1988;12:311

    Google Scholar 

  15. Moretti JL, Defer G, Cesaro P, Tamgac F, et al. Tomoscintigraphie cerebrale avec l'ECD Tc99m et l'IMP I123 comparaison des images précoces et tardives chez des patients ayant présenté un accident vasculaire subaigue. J Med Nucl Biophys 1991;15: 3: 273

    Google Scholar 

  16. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between 99mTc ECD and 99mTc HMPAO in healthy human subjects. J Nucl Med 1992;33: 480–484

    Google Scholar 

  17. Lassen NA. The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet 1966;11: 1113–1115

    Google Scholar 

  18. Bushnell DL, Gupta S, Mlcoch AG, Romyn A, Barnes WE, Kaplan E. Demonstration of focal hyperemia in acute cerebral infarction with iodine-123 iodoamphetamine. J Nucl Med 1987;28:1920–1923

    Google Scholar 

  19. Yatsu FM, Becker C, et al. Community hospital-based programs: North Carolina, Oregon, and New York. Stroke 1986;17:276

    Google Scholar 

  20. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1986;25: 638–643

    Google Scholar 

  21. Defer G, Moretti JL, Cesaro P, Sergent A, Raynaud C, Degos JD. Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery. Arch Neurol 1987;44: 715–718

    Google Scholar 

  22. Uemura K, Goto K, Ishii K, Ito Z, Hen R, Kawakami H. Sequential changes of regional cerebral circulation in cerebral infarction. Neuroradiology 1978;16:228–232

    Google Scholar 

  23. Olsen TS, Larsen B, Shiver EB, Herning M, Enevoldsen E, Lassen NA. Focal cerebral hyperemia in acute stroke. Incidence, pathophysiology and clinical significance. Stroke 1981;12: 598–607

    Google Scholar 

  24. Murase K, Tanada S, Inoue T, Sugawara Y, Kimura Y, Sakaki S, Hamamoto K. Kinetic behavior of Tc-99m ECD in the human brain using compartment analysis and dynamic SPECT: comparison with Tc-99m HMPAO. J Nucl Med 1992;33: 909

    Google Scholar 

  25. Garrett K, Villanueva J, Kuperus J, Giombetti R, Mena I. A comparison of regional cerebral blood flow with Xe 133 to SPECT Tc99m ECD. J Nucl Med 1988;29: 913

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: F. Tamgac

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamgac, F., Moretti, JL., Defer, G. et al. Non-matched images with 123I-IMP and 99mTc-bicisate single-photon emission tomography in the demonstration of focal hyperaemia during the subacute phase of an ischaemic stroke. Eur J Nucl Med 21, 254–257 (1994). https://doi.org/10.1007/BF00188674

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00188674

Key words

Navigation